Rune Nilsson (Former)
1 – 10 of 43
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2015
- 
                        Mark
        Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Role of CD8-positive cells in radioimmunotherapy utilizing (177)Lu-mAbs in an immunocompetent rat colon carcinoma model.
    
    - Contribution to journal › Article
 
- 2014
- 
                        Mark
        Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.
    
    - Contribution to journal › Article
 
- 2013
- 
                        Mark
        Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.
    
    - Contribution to journal › Article
 
- 
                        Mark
        The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.
    
    - Contribution to journal › Article
 
- 2012
- 
                        Mark
        Repeated Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Treatment with Unlabeled mAb BR96 After Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Use of Monte Carlo simulations with a realistic rat phantom for examining the correlation between hematopoietic system response and red marrow absorbed dose in Brown Norway rats undergoing radionuclide therapy with (177)Lu- and (90)Y-BR96 mAbs.
    
    - Contribution to journal › Article
 
